CBD vs. cannabis: can a compound from the same plant reduce use?

NCT ID NCT06575751

First seen May 06, 2026 · Last updated May 06, 2026

Summary

This study tests whether cannabidiol (CBD), a non-psychoactive compound from the cannabis plant, can help people who regularly use high-potency cannabis concentrates reduce their use and cravings. About 120 adults who use cannabis concentrates at least 4 times a week but are not trying to quit will take either 200 mg or 400 mg of CBD or a placebo daily for 4 weeks. Researchers will measure changes in cannabis use, blood THC levels, and subjective effects using a mobile lab.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANNABIS USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Colorado Anschutz Medical Campus

    RECRUITING

    Aurora, Colorado, 80045, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.